Mdb Capital Holdings Cl A (MDBH)

$4.36 +0.11 (2.59%)
Market Cap 53.45M
Revenue (ttm) 2.16M
Net Income (ttm) 11.69M
EPS (ttm) N/A
PE Ratio 5.25
Forward PE N/A
Profit Margin 541.20%
Debt to Equity Ratio 0.00
Volume 13,000
Avg Vol 5,262
Day's Range N/A - N/A
Shares Out 9.30M
Stochastic %K 7%
Beta 0.92
Analysts Strong Buy
Price Target N/A

Latest News on MDBH

Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

Apr 23, 2025, 11:52 AM EDT - 5 days ago

Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript

Apr 3, 2025, 11:16 AM EDT - 25 days ago

MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

Apr 1, 2025, 10:00 AM EDT - 27 days ago

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time

Mar 24, 2025, 8:50 AM EDT - 5 weeks ago

MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time

New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race

Mar 5, 2025, 10:00 AM EST - 7 weeks ago

New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

Feb 19, 2025, 8:25 AM EST - 2 months ago

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Feb 12, 2025, 8:50 AM EST - 2 months ago

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

Feb 10, 2025, 11:00 AM EST - 2 months ago

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change

Jan 7, 2025, 10:00 AM EST - 3 months ago

Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change

MDB Capital Holdings Provides Third Quarter 2024 Update

Nov 21, 2024, 4:05 PM EST - 5 months ago

MDB Capital Holdings Provides Third Quarter 2024 Update

Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

Nov 19, 2024, 9:05 AM EST - 5 months ago

Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time

Nov 15, 2024, 9:05 AM EST - 5 months ago

MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time

Invizyne Technologies Announces Closing of Initial Public Offering

Nov 14, 2024, 4:05 PM EST - 5 months ago

Invizyne Technologies Announces Closing of Initial Public Offering

Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing

Nov 13, 2024, 4:05 PM EST - 5 months ago

Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing

Invizyne Technologies Begins Trading on NASDAQ

Nov 13, 2024, 9:05 AM EST - 5 months ago

Invizyne Technologies Begins Trading on NASDAQ

Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024

Nov 12, 2024, 10:52 AM EST - 5 months ago

Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024

Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering

Nov 11, 2024, 4:05 PM EST - 6 months ago

Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

Jul 11, 2024, 4:05 PM EDT - 10 months ago

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

Jul 9, 2024, 11:00 AM EDT - 10 months ago

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

Jul 8, 2024, 4:16 PM EDT - 10 months ago

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

MDB Capital Expands Board, Appoints Daniel Torpey as New Director

Jun 20, 2024, 9:15 AM EDT - 11 months ago

MDB Capital Expands Board, Appoints Daniel Torpey as New Director

New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

May 22, 2024, 11:00 AM EDT - 1 year ago

New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

MDB Capital Holdings Unveils Unified Corporate Branding

May 22, 2024, 9:15 AM EDT - 1 year ago

MDB Capital Holdings Unveils Unified Corporate Branding

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

May 7, 2024, 1:52 PM EDT - 1 year ago

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

MDB Capital Holdings Year-End Update

Apr 17, 2024, 4:05 PM EDT - 1 year ago

MDB Capital Holdings Year-End Update

MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time

Apr 11, 2024, 4:05 PM EDT - 1 year ago

MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time

MDB Capital Holdings Issues Annual Letter to Shareholders

Jan 31, 2024, 9:00 AM EST - 1 year ago

MDB Capital Holdings Issues Annual Letter to Shareholders

MDB Capital Holdings Reports Third Quarter 2023 Results

Nov 15, 2023, 4:05 PM EST - 1 year ago

MDB Capital Holdings Reports Third Quarter 2023 Results

Michael Burns Joins Invizyne as Executive Vice President of Energy Transition

Nov 8, 2023, 4:05 PM EST - 1 year ago

Michael Burns Joins Invizyne as Executive Vice President of Energy Transition

Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort

Oct 17, 2023, 10:00 AM EDT - 1 year ago

Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort

Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy

Oct 11, 2023, 11:10 AM EDT - 1 year ago

Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy

MDB Capital Holdings Begins Trading on NASDAQ

Sep 21, 2023, 9:00 AM EDT - 1 year ago

MDB Capital Holdings Begins Trading on NASDAQ

MDB Capital Holdings Announces Closing of Public Offering of $20 Million

Sep 20, 2023, 9:00 AM EDT - 1 year ago

MDB Capital Holdings Announces Closing of Public Offering of $20 Million